Seelos Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
01 Dec 23 | BuyUS$99,999 | Raj Mehra | Individual | 75,757 | US$1.32 | |
30 Nov 23 | BuyUS$100,223 | Michael Golembiewski | Individual | 83,000 | US$1.21 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 5,280 | 0.0386% |
Individual Insiders | 273,886 | 2% |
Institutions | 2,506,588 | 18.3% |
General Public | 10,894,822 | 79.6% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 236.9%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
466,660 | US$158.3k | 104% | 0.06% | |||
463,851 | US$157.4k | 0% | 0.48% | |||
303,714 | US$103.1k | 913% | no data | |||
283,878 | US$96.3k | 64.6% | no data | |||
264,754 | US$89.8k | 0% | no data | |||
185,143 | US$62.8k | 69.3% | no data | |||
181,259 | US$61.5k | 775% | 0.01% | |||
111,615 | US$37.9k | -50.4% | no data | |||
86,869 | US$29.5k | 0.48% | no data | |||
70,163 | US$23.8k | 323% | no data | |||
69,728 | US$23.7k | 70.9% | no data | |||
55,964 | US$19.0k | -0.89% | no data | |||
40,536 | US$13.8k | 0% | no data | |||
40,000 | US$13.6k | 0% | 0.07% | |||
30,010 | US$10.2k | 499% | no data | |||
29,343 | US$10.0k | -27.4% | no data | |||
25,246 | US$8.6k | 0% | no data | |||
12,948 | US$4.4k | -1.26% | no data | |||
11,889 | US$4.0k | 0% | no data | |||
10,018 | US$3.4k | 0% | no data | |||
9,071 | US$3.1k | -3.6% | no data | |||
8,581 | US$2.9k | -59.7% | no data | |||
8,000 | US$2.7k | 60% | no data | |||
5,280 | US$1.8k | 0% | no data | |||
3,758 | US$1.3k | 3,450% | no data |